Corti vs Tempus AI
A detailed comparison to help you choose between Corti and Tempus AI.
🏆
Verdict: Tempus AI wins
Tempus AI scores 4.1/5, edging out Corti at 3.8/5. Cancer centers, molecular labs and health systems building precision-oncology programs that need sequencing, interpretation and data products under one roof — and pharma partners buying real-world data access.
Corti AI for emergency call centers | Tempus AI AI for precision medicine and clinical genomics | |
|---|---|---|
| Rating | 3.8 (1 review) | 4.1 (1 review) |
| Pricing Model | paid | paid |
| Starting Price | From $1000/mo | From $1000/mo |
| Best For | Healthcare software teams and digital-health vendors that want clinical-grade speech recognition, coding and documentation APIs with published usage pricing instead of an enterprise sales cycle. | Cancer centers, molecular labs and health systems building precision-oncology programs that need sequencing, interpretation and data products under one roof — and pharma partners buying real-world data access. |
| Free Tier | ||
| API Access | ||
| Team Features | ||
| Open Source | ||
| Tags | ssoteam features | ssoteam features |
| Visit Corti → | Visit Tempus AI → |
Corti
Pros
- + Public, usage-based pricing with $50 in free credits: speech-to-text from $0.0065/min and text APIs from $4 per million input tokens at time of writing
- + Medical tuning at the recognition layer: keyterm biasing for drug names, spoken punctuation, and 98.5% claimed formatted-entity recall on dosages and units
- + One credit wallet across speech-to-text, text generation, coding and model endpoints simplified my billing model in testing
- + Sovereign EU cloud option and healthcare-specific models, with European health-system customers including the NHS
- + Symphony for Speech-to-Text publishes concrete accuracy claims (1.4% realtime English WER) instead of marketing adjectives
Cons
- - It is developer infrastructure, not an end-user product; clinics cannot deploy it without a software team
- - The flagship accuracy figures are vendor benchmarks, not independent head-to-head trials
- - Independent peer-reviewed validation of clinical outcomes for the current platform is thin
- - The product surface spans several loosely joined layers, and the docs show the seams
- - The emergency-dispatch triage console that built the company's reputation is no longer the thing sold off the shelf
Tempus AI
Pros
- + FY2025 revenue of $1.3B with 126% net revenue retention and >$1.1B remaining contract value — verifiable public-company financials, not marketing claims
- + Complete assay portfolio in one relationship: xT/xR comprehensive profiling, xF+ liquid biopsy, MRD monitoring, Ambry hereditary testing and OneOme pharmacogenomics (national launch July 2026)
- + Tempus One answered voice queries against the patient's own clinical and molecular profile in my testing, with report citations instead of generic text
- + Paige Predict extends the platform into digital pathology — 123 biomarkers predicted from standard H&E slides across 16 cancer types (vendor-published validation)
- + Trial matching is built into the report workflow, which is the practical bottleneck for oncology coordinators
Cons
- - No self-serve access, no trial, and no published pricing of any kind — the $1,000 entry figure floating around listings could not be verified
- - Oncology-first scope; primary care and non-oncology specialties have little reason to engage
- - Still net-loss-making (-$245.0M in 2025), and the portfolio is stitched from four recent acquisitions (Ambry, Paige, OneOme, Deep 6)
- - Model-performance and data-library claims are company-published; independent third-party validation is thinner than the press-release volume suggests
- - Enterprise sales motion means long procurement cycles for health systems
Frequently Asked Questions
Which is better, Corti or Tempus AI?▼
Tempus AI scores higher at 4.1/5 vs 3.8/5 for Corti, making it the better-rated option in our comparison.
What is the difference between Corti and Tempus AI?▼
Corti: AI platform that listens to emergency calls in real-time and assists dispatchers with triage, protocol adherence, and diagnosis. Tempus AI: Tempus AI runs clinical and genomic sequencing and builds the diagnostics and data products used in precision oncology and other specialties.
Is Corti or Tempus AI more affordable?▼
Corti starts at €1000/mo, Tempus AI starts at €1000/mo. Check the comparison table above for current pricing.
Stay in the loop
Get weekly updates on the best new AI tools, deals, and comparisons.
No spam. Unsubscribe anytime.